Convalescent Plasma News and Research

RSS
Study reports persistent SARS-CoV-2 with increasing viral variants in pediatric patients

Study reports persistent SARS-CoV-2 with increasing viral variants in pediatric patients

Early antibody response predicts COVID-19 outcome

Early antibody response predicts COVID-19 outcome

Concerning mutation in New York SARS-CoV-2 should be monitored, warn researchers

Concerning mutation in New York SARS-CoV-2 should be monitored, warn researchers

Could small synthetic antigen proteins be diagnostic tools for SARS-CoV-2?

Could small synthetic antigen proteins be diagnostic tools for SARS-CoV-2?

New SARS-CoV-2 B.1.526 variant emerges in New York

New SARS-CoV-2 B.1.526 variant emerges in New York

South African SARS-CoV-2 variant partly resistant to neutralization by mRNA vaccine, says study

South African SARS-CoV-2 variant partly resistant to neutralization by mRNA vaccine, says study

Researchers develop new tool for predicting the effects of SARS-CoV-2 missense variants

Researchers develop new tool for predicting the effects of SARS-CoV-2 missense variants

Inhalable nanobody shows potent anti-SARS-CoV-2 activity in vivo

Inhalable nanobody shows potent anti-SARS-CoV-2 activity in vivo

Researchers investigate the duration of the immune response to SARS-CoV-2

Researchers investigate the duration of the immune response to SARS-CoV-2

Study reports lasting immune response in convalescent COVID-19 patients

Study reports lasting immune response in convalescent COVID-19 patients

Chicken-derived antibody shows potent neutralizing capacity against SARS-CoV-2 in vitro

Chicken-derived antibody shows potent neutralizing capacity against SARS-CoV-2 in vitro

How does the SARS-CoV-2 E484K mutation increase viral fitness?

How does the SARS-CoV-2 E484K mutation increase viral fitness?

Convalescent plasma shows CD8+ T cell responses to SARS-CoV-2 variants

Convalescent plasma shows CD8+ T cell responses to SARS-CoV-2 variants

Clonally expanded plasma cell lineages in SARS-CoV-2 produce specific neutralizing antibodies

Clonally expanded plasma cell lineages in SARS-CoV-2 produce specific neutralizing antibodies

Researchers observe rapid increase of SARS-CoV-2 antibodies in plasma over pandemic's course

Researchers observe rapid increase of SARS-CoV-2 antibodies in plasma over pandemic's course

SARS-CoV-2 South Africa and Brazil variants show resistance to therapeutic antibodies

SARS-CoV-2 South Africa and Brazil variants show resistance to therapeutic antibodies

SARS-CoV-2 evolves antibody resistance in immunocompromised patient

SARS-CoV-2 evolves antibody resistance in immunocompromised patient

Polyclonal SARS-CoV-2 antibody shows potent neutralizing activity in vitro

Polyclonal SARS-CoV-2 antibody shows potent neutralizing activity in vitro

Can early use of colchicine reduce COVID-19 mortality?

Can early use of colchicine reduce COVID-19 mortality?

COVID-19 pandemic and nanotechnology

COVID-19 pandemic and nanotechnology